Clinical trial
Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Chinese Primary Angle Closure Glaucoma
NCT02964676 is registered in ClinicalTrials.gov with Shanghai Eye Disease Prevention and Treatment Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Efficacy and Safety of Minimally Invasive Glaucoma Surgery on Chinese Primary Angle Closure Glaucoma
- Lead sponsor
- Shanghai Eye Disease Prevention and Treatment Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 31, 2017
- Completion date
- December 31, 2019
- Enrollment
- 246 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.